# A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide

> **NCT00820885** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 95 (actual)

## Conditions studied

- Pharmacokinetics and Safety of Elevated Doses

## Interventions

- **DRUG:** teduglutide
- **DRUG:** teduglutide
- **DRUG:** tedguglutide

## Key facts

- **NCT ID:** NCT00820885
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-06
- **Primary completion:** 2007-04-23
- **Final completion:** 2007-04-23
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2021-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820885, "A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of Teduglutide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00820885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*